James Jett, M.D. has served as Co-Chief Medical Officer of Biodesix since October 2019, after the acquisition of Oncimmune LLC where he served as Chief Medical Officer. Dr. Jett is a board-certified physician in pulmonary medicine and served on the consulting staff of Mayo Clinic in Rochester, MN for 28 years.
Next, Dr. Jett joined the Denver-based National Jewish Health faculty as a professor of medicine from 2010 to 2015. His research interests have focused on screening, diagnosis and treatment of lung cancer.
From 2006 to 2012, Dr. Jett served as the Editor-in-Chief of the Journal of Thoracic Oncology and from 2008 to 2017 as the Co-Editor of the Lung Cancer Section of the premier medical electronic textbook Up-To-Date. Dr. Jett has held professional memberships with numerous organizations such as the American Thoracic Society, International Association for the Study of Lung Cancer, American Society of Clinical Oncology, North Central Cancer Treatment Group, and the American College of Chest Physicians.
Dr. Jett received his doctorate degree from the University of Missouri and completed his internal medicine and pulmonary medicine training at the Mayo Clinic. Dr. Jett’s academic honors include the 2013 IASLC Merit Award, Clinical Educator Award from the ATS Assembly on Clinics Problems, 2014; selection for the 2015 Edition of Who’s Who in America; and the Lifetime Achievement Award from the ATS Assembly on Thoracic Oncology, 2015.